01:14 , Aug 17, 2006 |  BC Extra  |  Financial News

TolerRx raises $35.6 million

TolerRx ( Cambridge , Mass.) raised $35.6 million in a series E round led by new investor FrontPoint Partners. Other new investors Mesirow Financial; Swiss Re; QVT Fund; IBT Management Corp.; Brookstone Capital; and the...
07:00 , Apr 4, 2005 |  BioCentury  |  Finance

Ebb & Flow

TolerRx has been quietly busy since it pulled its IPO last summer. After hitting a series of milestones, the company last week announced a $30 million series D round. President and CEO Douglas Ringler said...
02:29 , Mar 30, 2005 |  BC Extra  |  Top Story

TolerRx raises $31M

TolerRx ( Cambridge , Mass.) raised $31 million in a series D round led by Bear Stearns Health Innoventures. Other investors included NIF Ventures; Skyline Ventures; HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
07:00 , Sep 1, 2003 |  BioCentury  |  Finance

Ebb & Flow

A horse kept in the stable too long can turn a measured trot into a mad sprint. Not one IPO has gotten done yet, but 10 companies are already in the queue, with about $800...
08:00 , Jan 6, 2003 |  BioCentury  |  Finance

Ebb & Flow

Swiss venture capital firms HBM BioVentures and NMT New Medical Technologies are joining forces to create a firm with about CHF830 million ($640 million) under management. The merged firms, which both invest heavily in biotech...
08:00 , Jan 3, 2003 |  BC Extra  |  Top Story

TolerRx raises $35M; signs DNA deal

TolerRx (Cambridge, Mass.) raised $35 million in a series C round led by Skyline Ventures. Other investors included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal Services; Genentech (DNA); Lehman Brothers Healthcare Fund; Yasuda...